Azithromycin Therapy in PreSchoolers with a Severe Wheezing Episode Diagnosed at the Emergency Department (AZ-SWED)

← Back to all studies

Azithromycin Therapy in PreSchoolers with a Severe Wheezing Episode Diagnosed at the Emergency Department (AZ-SWED)

Health Condition: Asthma
Health Impact Domain: -

Summary

Every year in the United States, almost 2.2 million children aged 2-5 years have wheezing and difficulty to breathe severe enough to require their caregivers to take them to Emergency Departments (ED). No other age group has such a high burden for asthma-like symptoms. Approximately $2 billion are spent each year on direct and indirect health care costs including loss of wages. Finding better ways to treat acute preschool wheezing illnesses and decrease severity of symptoms and potentially admissions is a national public health priority.

Key Publications

Related Media

-

This website is supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) as part of the Emergency Medical Services for Children Data Center award totaling $3,200,000 with 0% financed with non-governmental sources. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by HRSA, HHS, or the U.S. Government. For more information, please visit HRSA.gov.

PECARN is committed to making health care information accessible for everyone. Please contact melissa.laws@hsc.utah.edu if you encounter a document, such as an older PDF brochure or historical form, that has not been optimized for your screen reader. We consider these remediation requests a top priority and will provide an accessible version as soon as possible.